Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

ACADACADIA PHARMACEUTICALS INC

Nasdaq · CIK 0001070494
Filer categoryLarge accelerated filer
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts390

Identity from submissions API

NameACADIA PHARMACEUTICALS INC
CIK0001070494
TickersACAD
ExchangesNasdaq
Entity typeoperating
CategoryLarge accelerated filer
SIC2834 Pharmaceutical Preparations
EIN061376651
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone858-558-2871
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
12830 EL CAMINO REAL
SUITE 400
SAN DIEGO
CA
92130
CA
Mailing address
12830 EL CAMINO REAL
SUITE 400
SAN DIEGO
CA
92130
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1382 filing rows loaded from submissions recent; extra archives: CIK0001070494-submissions-001.json (381 filings, 2000-12-21 to 2010-11-07).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-10 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000093751-26-000603 005-80011 261537757 34 8079
2026-11-05 10-Q 10-Q 0001193125-26-447794 000-50768 261524038 34 11010361 1 1
2026-11-04 8-K 8-K 2.02,9.01 0001193125-26-447276 000-50768 261522382 34 525452 1 1
2026-10-30 4 xslF345X06/form4-10312026_121045.xml 0001899977-26-000010 7067
2026-10-23 8-K 8-K 5.02 0001193125-26-430596 000-50768 261482806 34 158936 1 1
2026-09-24 8-K 8-K 7.01,8.01,9.01 0001193125-26-401157 000-50768 261405361 34 190565 1 1
2026-09-11 8-K 8-K 8.01,9.01 0001193125-26-389400 000-50768 261375221 34 604139 1 1
2026-08-07 4 xslF345X06/form4-08072026_060801.xml 0001899977-26-000008 16148
2026-08-07 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000093751-26-000400 005-80011 261251503 34 8108
2026-08-05 144 xsl144X01/primary_doc.xml 0001967940-26-000042 000-50768 261244443 33 4532
2026-08-05 10-Q 10-Q 0001193125-26-333243 000-50768 261240569 34 9489681 1 1
2026-08-04 8-K 8-K 2.02,9.01 0001193125-26-332858 000-50768 261238959 34 495655 1 1
2026-07-31 4 xslF345X06/form4-07312026_060701.xml 0001861477-26-000005 10633
2026-06-29 4 xslF345X06/form4-06292026_060601.xml 0001816160-26-000009 5493
2026-06-26 144 xsl144X01/primary_doc.xml 0001967940-26-000036 000-50768 261128034 33 4513
2026-06-10 S-8 S-8 0001193125-26-265809 333-296668 261079658 33 184575 1 1
2026-06-02 4 4 0001193125-26-253632 29393
2026-06-01 4 xslF345X06/form4-06012026_060612.xml 0001177917-26-000009 11861
2026-06-01 4 xslF345X06/form4-06012026_060610.xml 0001865210-26-000002 11845
2026-06-01 4 xslF345X06/form4-06012026_060608.xml 0001365619-26-000002 12374
2026-06-01 4 xslF345X06/form4-06012026_060606.xml 0001604689-26-000009 12392
2026-06-01 4 xslF345X06/form4-06012026_060603.xml 0001826361-26-000002 12407
2026-06-01 4 xslF345X06/form4-06012026_060601.xml 0001560782-26-000002 12401
2026-05-29 8-K 8-K 5.02,5.07,9.01 0001193125-26-248242 000-50768 261044275 34 354713 1 1
2026-05-27 4 xslF345X06/form4-05272026_060501.xml 0001816160-26-000008 5525
2026-05-26 144 xsl144X01/primary_doc.xml 0001950047-26-005016 000-50768 261019613 33 8692
2026-05-07 10-Q 10-Q 0001193125-26-209731 000-50768 26950280 34 8393969 1 1
2026-05-06 8-K 8-K 2.02,9.01 0001193125-26-209253 000-50768 26949382 34 418576 1 1
2026-05-05 4 xslF345X06/form4-05052026_060511.xml 0001816160-26-000007 9578
2026-05-05 4 xslF345X06/form4-05052026_060501.xml 0001899977-26-000007 9587
2026-05-01 8-K 8-K 5.02,7.01,9.01 0001193125-26-197957 000-50768 26927526 34 183930 1 1
2026-04-28 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100121-26-000077 005-80011 26907329 34 7368
2026-04-24 ARS ARS 0001193125-26-174167 000-50768 26889973 34 2169092
2026-04-24 DEF 14A DEF 14A 0001193125-26-174163 000-50768 26889967 34 7440104 1 1
2026-04-07 4 xslF345X06/form4-04072026_110411.xml 0001899977-26-000005 9072
2026-04-07 4 xslF345X06/form4-04072026_110435.xml 0001816160-26-000005 9576
2026-03-26 4 xslF345X06/form4-03262026_080310.xml 0001816838-26-000003 9494
2026-03-26 4 xslF345X06/form4-03262026_080306.xml 0001861477-26-000003 9095
2026-03-26 4 xslF345X06/form4-03262026_080308.xml 0001568249-26-000005 9099
2026-03-26 4 xslF345X06/form4-03262026_080304.xml 0001816160-26-000003 15796
2026-03-26 4 xslF345X06/form4-03262026_080301.xml 0001899977-26-000003 15807
2026-03-26 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-000519 005-80011 26797294 34 7187
2026-03-20 4 xslF345X06/form4-03202026_100313.xml 0001604689-26-000006 12783
2026-03-20 3 xslF345X06/form3-03202026_100310.xml 0001604689-26-000005 6620
2026-03-10 4 xslF345X05/form4-03102026_060314.xml 0001816160-26-000002 7900
2026-03-10 4 xslF345X05/form4-03102026_060312.xml 0001568249-26-000004 7896
2026-03-10 4 xslF345X05/form4-03102026_060310.xml 0001899977-26-000002 7911
2026-03-10 4 xslF345X05/form4-03102026_060309.xml 0001996325-26-000002 7907
2026-03-10 4 xslF345X05/form4-03102026_060307.xml 0001861477-26-000002 7934
2026-03-10 4 xslF345X05/form4-03102026_060303.xml 0001816838-26-000002 8066
2026-03-05 8-K 8-K 5.02 0001193125-26-092213 000-50768 26723872 34 158626 1 1
2026-02-26 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-26-020778 005-80011 26691500 34 27729
2026-02-26 10-K 10-K 0001193125-26-072519 000-50768 26681011 34 19407292 1 1
2026-02-25 8-K 8-K 2.02,9.01 0001193125-26-071674 000-50768 26678957 34 559598 1 1
2026-02-10 4 xslF345X05/form4-02102026_060201.xml 0001568249-26-000002 9730
2026-01-13 8-K 8-K 2.02,7.01,9.01 0001193125-26-011706 000-50768 26530034 34 163694 1 1
2025-11-19 4 xslF345X05/form4-11192025_061103.xml 0001899977-25-000006 13886
2025-11-19 4 xslF345X05/form4-11192025_061101.xml 0001816160-25-000004 13877
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001493215-25-000033 005-80011 251481393 34 10389
2025-11-12 4 xslF345X05/form4-11122025_061101.xml 0001560782-25-000006 5149
2025-11-10 144 xsl144X01/primary_doc.xml 0001950047-25-008659 000-50768 251467663 33 7074
2025-11-06 10-Q 10-Q 0001193125-25-267453 000-50768 251455502 34 9274021 1 1
2025-11-05 8-K 8-K 2.02,9.01 0001193125-25-266959 000-50768 251454139 34 453581 1 1
2025-11-03 8-K 8-K 5.02 0001193125-25-262610 000-50768 251444452 34 152244 1 1
2025-09-16 4 xslF345X05/form4-09162025_100915.xml 0001899977-25-000004 6906
2025-09-03 4 xslF345X05/form4-09032025_060901.xml 0001415889-25-023592 5156
2025-08-19 4 xslF345X05/form4-08192025_060803.xml 0001415889-25-022359 5381
2025-08-18 144 xsl144X01/primary_doc.xml 0001967940-25-000057 000-50768 251228326 33 4524
2025-08-07 10-Q 10-Q 0000950170-25-104295 000-50768 251190886 34 11203030 1 1
2025-08-06 8-K 8-K 2.02,9.01 0000950170-25-104092 000-50768 251189897 34 454974 1 1
2025-06-10 8-K 8-K 8.01 0001193125-25-138452 000-50768 251037124 34 140083 1 1
2025-06-05 4 xslF345X05/form4-06052025_060604.xml 0001415889-25-015832 5105
2025-06-04 144 xsl144X01/primary_doc.xml 0001950047-25-003846 000-50768 251023631 33 5868
2025-06-02 4 xslF345X05/form4-06022025_060611.xml 0001415889-25-015275 11677
2025-06-02 4 xslF345X05/form4-06022025_060609.xml 0001415889-25-015274 11708
2025-06-02 4 xslF345X05/form4-06022025_060607.xml 0001415889-25-015273 11724
2025-06-02 4 xslF345X05/form4-06022025_060605.xml 0001415889-25-015272 11736
2025-06-02 4 xslF345X05/form4-06022025_060603.xml 0001415889-25-015271 11730
2025-06-02 4 xslF345X05/form4-06022025_060601.xml 0001415889-25-015270 11703
2025-06-02 4 4 0000950170-25-080214 28922
2025-05-29 8-K 8-K 5.07 0001193125-25-130620 000-50768 251003331 34 147882 1 1
2025-05-23 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001730 333-287145 25984035 33 1763
2025-05-21 CORRESP filename1.htm 0001193125-25-123577 7667
2025-05-20 8-K 8-K 1.01,8.01 0001193125-25-123175 000-50768 25969346 34 147650 1 1
2025-05-19 4 xslF345X05/form4-05202025_120553.xml 0001415889-25-013742 6588
2025-05-19 4 xslF345X05/form4-05202025_120539.xml 0001415889-25-013741 5086
2025-05-16 144 xsl144X01/primary_doc.xml 0001967940-25-000026 000-50768 25960437 33 4479
2025-05-16 144 xsl144X01/primary_doc.xml 0001967940-25-000025 000-50768 25960408 33 4466
2025-05-14 UPLOAD filename1.pdf 0000000000-25-005177 333-287145 40136
2025-05-09 S-3 FORM S-3 0001193125-25-116883 333-287145 25930400 33 399803 1 1
2025-05-08 10-Q 10-Q 0000950170-25-066231 000-50768 25923479 34 8094988 1 1
2025-05-07 8-K 8-K 2.02,9.01 0000950170-25-065672 000-50768 25921508 34 384531 1 1
2025-05-02 4 xslF345X05/form4-05032025_120531.xml 0001415889-25-011875 8927
2025-05-02 4 xslF345X05/form4-05022025_110505.xml 0001415889-25-011872 8936
2025-04-25 ARS ARS 0000950170-25-058833 000-50768 25874976 34 1970156
2025-04-25 DEF 14A DEF 14A 0000950170-25-058827 000-50768 25874931 34 11405764 1 1
2025-04-16 8-K 8-K 5.03,9.01 0001193125-25-082809 000-50768 25843024 34 354494 1 1
2025-04-08 4 xslF345X05/form4-04082025_110409.xml 0001415889-25-010424 8938
2025-04-08 4 xslF345X05/form4-04082025_110455.xml 0001415889-25-010423 8930
2025-03-26 4 xslF345X05/form4-03272025_120357.xml 0001415889-25-009075 13514
2025-03-26 4 xslF345X05/form4-03272025_120306.xml 0001415889-25-009074 13529
2025-03-26 4 xslF345X05/form4-03272025_120324.xml 0001415889-25-009073 8778
2025-03-26 4 xslF345X05/form4-03262025_110352.xml 0001415889-25-009068 7933
2025-03-26 4 xslF345X05/form4-03262025_110347.xml 0001415889-25-009067 8068
2025-03-06 4 xslF345X05/form4-03062025_060312.xml 0001415889-25-007299 4642
2025-03-06 144 xsl144X01/primary_doc.xml 0001972362-25-000241 000-50768 25714320 33 4832
2025-02-27 10-K 10-K 0000950170-25-029253 000-50768 25680967 34 19850382 1 1
2025-02-26 8-K 8-K 2.02,9.01 0000950170-25-027759 000-50768 25670242 34 460364 1 1
2025-02-25 4 xslF345X05/form4-02252025_110245.xml 0001415889-25-005575 8934
2025-02-25 4 xslF345X05/form4-02252025_110254.xml 0001415889-25-005574 8945
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-020492 005-80011 25623685 34 10236
2025-02-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-25-001609 005-80011 25599095 34 12021
2024-12-11 8-K 8-K 2.01 0001193125-24-275595 000-50768 241541798 34 144889 1 1
2024-12-10 4 xslF345X05/form4-12102024_111227.xml 0001415889-24-028884 8019
2024-12-10 3 xslF345X02/form3-12102024_111214.xml 0001415889-24-028883 6519
2024-11-20 8-K 8-K 5.02 0001193125-24-262556 000-50768 241480822 34 144816 1 1
2024-11-19 4 xslF345X05/form4-11202024_011138.xml 0001415889-24-027294 13949
2024-11-19 4 xslF345X05/form4-11202024_011147.xml 0001415889-24-027293 13936
2024-11-19 4 xslF345X05/form4-11202024_011103.xml 0001415889-24-027292 13671
2024-11-14 SC 13G/A ACADIA PHARMACEUTICALS INC 0000902664-24-006501 005-80011 241457017 34 61434
2024-11-07 10-Q 10-Q 0000950170-24-122513 000-50768 241432413 34 7996674 1 1
2024-11-06 8-K 8-K 2.02,9.01 0000950170-24-122322 000-50768 241431111 34 386947 1 1
2024-10-15 4 xslF345X05/form4-10152024_061001.xml 0001415889-24-025148 7025
2024-09-25 4 xslF345X05/form4-09252024_100900.xml 0001415889-24-023975 5910
2024-09-25 3 xslF345X02/form3-09252024_100941.xml 0001415889-24-023974 6625
2024-09-23 S-8 S-8 0001193125-24-223796 333-282295 241316886 33 452304 1 1
2024-09-23 8-K 8-K 5.02,9.01 0001193125-24-223726 000-50768 241316608 34 273641 1 1
2024-08-20 4 xslF345X05/form4-08202024_100820.xml 0001415889-24-021731 9135
2024-08-20 4 xslF345X05/form4-08202024_100820.xml 0001415889-24-021726 9328
2024-08-20 4 xslF345X05/form4-08202024_100838.xml 0001415889-24-021724 9302
2024-08-20 S-8 POS S-8 POS 0001193125-24-203704 333-269611 241225780 33 64157
2024-08-20 S-8 POS S-8 POS 0001193125-24-203703 333-266680 241225740 33 64157
2024-08-20 S-8 POS S-8 POS 0001193125-24-203702 333-232981 241225712 33 64157
2024-08-20 S-8 POS S-8 POS 0001193125-24-203700 333-226834 241225662 33 64157
2024-08-20 S-8 POS S-8 POS 0001193125-24-203694 333-219785 241225635 33 64157
2024-08-20 S-8 POS S-8 POS 0001193125-24-203689 333-213109 241225591 33 64157
2024-08-20 S-8 POS S-8 POS 0001193125-24-203684 333-207971 241225537 33 64157
2024-08-20 S-8 POS S-8 POS 0001193125-24-203678 333-190400 241225487 33 64157
2024-08-20 S-8 POS S-8 POS 0001193125-24-203675 333-168667 241225467 33 64157
2024-08-13 4 xslF345X05/form4-08132024_060801.xml 0001415889-24-021243 7965
2024-08-07 10-Q 10-Q 0000950170-24-092163 000-50768 241180997 34 7705381 1 1
2024-08-06 8-K 8-K 2.02,9.01 0000950170-24-091826 000-50768 241179411 34 387395 1 1
2024-06-11 4 xslF345X05/form4-06112024_060601.xml 0001415889-24-016416 9686
2024-05-31 4 xslF345X05/form4-05312024_060517.xml 0001415889-24-015089 15197
2024-05-31 4 xslF345X05/form4-05312024_060514.xml 0001415889-24-015088 15249
2024-05-31 4 xslF345X05/form4-05312024_060512.xml 0001415889-24-015087 15227
2024-05-31 4 xslF345X05/form4-05312024_060509.xml 0001415889-24-015086 15225
2024-05-31 4 xslF345X05/form4-05312024_060506.xml 0001415889-24-015085 15180
2024-05-31 4 xslF345X05/form4-05312024_060502.xml 0001415889-24-015084 15196
2024-05-31 4 4 0000950170-24-067310 28309
2024-05-29 8-K 8-K 5.02,5.07 0001193125-24-149336 000-50768 24999731 34 165939 1 1
2024-05-29 S-8 POS S-8 POS 0001193125-24-149286 333-266680 24999345 33 87877
2024-05-29 S-8 POS S-8 POS 0001193125-24-149285 333-269611 24999335 33 87877
2024-05-29 S-8 POS S-8 POS 0001193125-24-149284 333-232981 24999325 33 87877
2024-05-29 S-8 POS S-8 POS 0001193125-24-149282 333-226834 24999310 33 87877
2024-05-29 S-8 POS S-8 POS 0001193125-24-149281 333-219785 24999309 33 87877
2024-05-29 S-8 POS S-8 POS 0001193125-24-149278 333-213109 24999297 33 87877
2024-05-29 S-8 POS S-8 POS 0001193125-24-149277 333-207971 24999239 33 87877
2024-05-29 S-8 POS S-8 POS 0001193125-24-149275 333-190400 24999234 33 87877
2024-05-29 S-8 POS S-8 POS 0001193125-24-149272 333-168667 24999228 33 87877
2024-05-29 S-8 S-8 0001193125-24-149130 333-279784 24998242 33 383149
2024-05-09 10-Q 10-Q 0000950170-24-056077 000-50768 24928007 34 7646097 1 1
2024-05-08 8-K 8-K 2.02,9.01 0000950170-24-055647 000-50768 24926099 34 330812 1 1
2024-05-03 4 xslF345X05/form4-05032024_060510.xml 0001415889-24-012237 9456
2024-05-03 4 xslF345X05/form4-05032024_060515.xml 0001415889-24-012239 9452
2024-05-03 4 xslF345X05/form4-05032024_060507.xml 0001415889-24-012236 9447
2024-05-03 4 xslF345X05/form4-05032024_060513.xml 0001415889-24-012238 9427
2024-04-26 ARS ARS 0000950170-24-049205 000-50768 24884286 34 6823121
2024-04-26 DEF 14A DEF 14A 0000950170-24-049182 000-50768 24884141 34 9581834 1 1
2024-04-15 3 xslF345X02/form3-04152024_100430.xml 0001415889-24-010816 6788
2024-04-09 4 xslF345X05/form4-04092024_060410.xml 0001415889-24-010604 15422
2024-04-09 4 xslF345X05/form4-04092024_060407.xml 0001415889-24-010603 9456
2024-04-09 4 xslF345X05/form4-04092024_060403.xml 0001415889-24-010602 15200
2024-04-09 4 xslF345X05/form4-04092024_060401.xml 0001415889-24-010601 9460
2024-03-27 4 xslF345X05/form4-03282024_120355.xml 0001415889-24-009273 7914
2024-03-27 4 xslF345X05/form4-03272024_110355.xml 0001415889-24-009272 11532
2024-03-27 4 xslF345X05/form4-03272024_110307.xml 0001415889-24-009271 9121
2024-03-27 4 xslF345X05/form4-03272024_110354.xml 0001415889-24-009270 11535
2024-03-11 8-K 8-K 8.01 0001193125-24-064791 000-50768 24737979 34 143510 1 1
2024-02-28 10-K 10-K 0000950170-24-021473 000-50768 24688988 34 15104598 1 1
2024-02-27 4 xslF345X05/form4-02272024_110237.xml 0001415889-24-005577 12445
2024-02-27 4 xslF345X05/form4-02272024_110225.xml 0001415889-24-005575 12443
2024-02-27 4 xslF345X05/form4-02272024_110201.xml 0001415889-24-005574 12414
2024-02-27 4 xslF345X05/form4-02272024_110210.xml 0001415889-24-005572 12415
2024-02-27 8-K 8-K 2.02,9.01 0000950170-24-021169 000-50768 24686964 34 390760 1 1
2024-02-14 SC 13G p24-0713sc13g.htm 0000902664-24-001543 005-80011 24632226 34 69663
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-020162 005-80011 24627261 34 13087
2024-02-09 SC 13G/A filing.txt 0000315066-24-000977 005-80011 24611377 34 8314
2024-02-08 4 xslF345X05/form4-02082024_100202.xml 0001415889-24-003039 7940
2024-02-08 3 xslF345X02/form3-02082024_100241.xml 0001415889-24-003034 6720
2024-01-31 8-K 8-K 5.02 0001193125-24-019903 000-50768 24580464 34 144427 1 1
2024-01-26 SC 13G/A us0042251084_012624.txt 0001086364-24-004855 005-80011 24569147 34 13725
2024-01-09 4 FORM 4 SUBMISSION 0001209191-24-001269 9985
2024-01-09 4 FORM 4 SUBMISSION 0001209191-24-001268 9465
2024-01-09 4 FORM 4 SUBMISSION 0001209191-24-001267 9410
2023-12-15 4 FORM 4 SUBMISSION 0001209191-23-058891 4834
2023-12-15 144 xsl144X01/primary_doc.xml 0001967940-23-000063 000-50768 231489529 33 4916
2023-11-28 4 FORM 4 SUBMISSION 0001209191-23-056827 4716
2023-11-21 4 FORM 4 SUBMISSION 0001209191-23-056355 13941
2023-11-21 4 FORM 4 SUBMISSION 0001209191-23-056357 13677
2023-11-21 4 FORM 4 SUBMISSION 0001209191-23-056354 13897
2023-11-21 8-K 8-K 8.01 0001193125-23-281574 000-50768 231429110 34 146248 1 1
2023-11-03 10-Q 10-Q 0000950170-23-058436 000-50768 231373954 34 8599110 1 1
2023-11-02 8-K 8-K 2.02,9.01 0000950170-23-058254 000-50768 231372688 34 454337 1 1
2023-10-16 4 FORM 4 SUBMISSION 0001209191-23-052884 7056
2023-10-06 4 FORM 4 SUBMISSION 0001209191-23-052390 9256
2023-10-06 4 FORM 4 SUBMISSION 0001209191-23-052389 9250
2023-09-19 4 FORM 4 SUBMISSION 0001209191-23-050072 5366
2023-09-15 144 xsl144X01/primary_doc.xml 0001967940-23-000045 000-50768 231257635 33 4968
2023-08-23 4 FORM 4 SUBMISSION 0001209191-23-047125 5564
2023-08-21 144 xsl144X01/primary_doc.xml 0001967940-23-000036 000-50768 231187954 33 5504
2023-08-03 10-Q 10-Q 0000950170-23-037458 000-50768 231137591 34 11116295 1 1
2023-08-02 8-K 8-K 2.02,9.01 0000950170-23-037216 000-50768 231136066 34 539647 1 1
2023-07-18 4 FORM 4 SUBMISSION 0001209191-23-042641 9306
2023-07-18 8-K 8-K 1.01,2.02,9.01 0001193125-23-188839 000-50768 231094257 34 212091 1 1
2023-07-14 144 xsl144X01/primary_doc.xml 0001967940-23-000026 000-50768 231088427 33 5820
2023-07-13 4 FORM 4 SUBMISSION 0001209191-23-042246 6896
2023-07-13 144 xsl144X01/primary_doc.xml 0001967940-23-000025 000-50768 231085998 33 9306
2023-06-16 4 FORM 4 SUBMISSION 0001209191-23-037932 4841
2023-06-15 144 xsl144X01/primary_doc.xml 0001967940-23-000021 000-50768 231016552 33 5509
2023-06-14 4 FORM 4 SUBMISSION 0001209191-23-037106 5258
2023-06-12 4 FORM 4 SUBMISSION 0001209191-23-036529 8874
2023-06-12 144 xsl144X01/primary_doc.xml 0001967940-23-000018 000-50768 231007731 33 4409
2023-06-05 4 FORM 4 SUBMISSION 0001209191-23-034699 19006
2023-06-05 4 FORM 4 SUBMISSION 0001209191-23-034698 7933
2023-06-05 4 FORM 4 SUBMISSION 0001209191-23-034697 19030
2023-06-05 4 FORM 4 SUBMISSION 0001209191-23-034696 18896
2023-06-05 4 FORM 4 SUBMISSION 0001209191-23-034695 19057
2023-06-05 4 FORM 4 SUBMISSION 0001209191-23-034694 19227
2023-06-05 4 FORM 4 SUBMISSION 0001209191-23-034482 26803
2023-06-02 8-K 8-K 5.07 0001193125-23-159833 000-50768 23988765 34 160859 1 1
2023-05-24 SC 13D/A SC 13D/A 0001104659-23-064183 005-80011 23955057 34 156452
2023-05-24 4 FORM 4 SUBMISSION 0001209191-23-031917 56192
2023-05-19 4 FORM 4 SUBMISSION 0001209191-23-031245 13157
2023-05-19 4 FORM 4 SUBMISSION 0001209191-23-031243 13173
2023-05-19 4 FORM 4 SUBMISSION 0001209191-23-031241 13169
2023-05-08 10-Q 10-Q 0000950170-23-018927 000-50768 23899096 34 8057782 1 1
2023-05-08 8-K 8-K 2.02,9.01 0000950170-23-018800 000-50768 23897797 34 430253 1 1
2023-05-03 4 FORM 4 SUBMISSION 0001209191-23-027207 7935
2023-05-03 4 FORM 4 SUBMISSION 0001209191-23-027206 7907
2023-05-03 4 FORM 4 SUBMISSION 0001209191-23-027205 7939
2023-05-03 4 FORM 4 SUBMISSION 0001209191-23-027204 7917
2023-05-03 4 FORM 4 SUBMISSION 0001209191-23-027203 7932
2023-05-02 4 FORM 4 SUBMISSION 0001209191-23-026746 8814
2023-05-02 4 FORM 4 SUBMISSION 0001209191-23-026744 8855
2023-05-02 4 FORM 4 SUBMISSION 0001209191-23-026742 8816
2023-05-01 ARS ARS 0000950170-23-015972 000-50768 23868790 34 22136137
2023-05-01 DEF 14A DEF 14A 0000950170-23-015969 000-50768 23868762 34 6026037 1 1
2023-04-11 4 FORM 4 SUBMISSION 0001209191-23-024061 9371
2023-04-07 4 FORM 4 SUBMISSION 0001209191-23-023865 8842
2023-04-07 4 FORM 4 SUBMISSION 0001209191-23-023864 9348
2023-04-07 4 FORM 4 SUBMISSION 0001209191-23-023863 9357
2023-04-07 4 FORM 4 SUBMISSION 0001209191-23-023862 9331
2023-04-07 4 FORM 4 SUBMISSION 0001209191-23-023861 9337
2023-03-13 8-K 8-K 8.01 0001193125-23-068406 000-50768 23725598 34 144549 1 1
2023-02-28 10-K 10-K 0000950170-23-004757 000-50768 23677316 34 16635995 1 1
2023-02-28 8-K 8-K 2.02,9.01 0000950170-23-004753 000-50768 23677294 34 511404 1 1
2023-02-27 4 FORM 4 SUBMISSION 0001209191-23-013471 8809
2023-02-27 4 FORM 4 SUBMISSION 0001209191-23-013470 8819
2023-02-27 4 FORM 4 SUBMISSION 0001209191-23-013472 8791
2023-02-27 4 FORM 4 SUBMISSION 0001209191-23-013469 8799
2023-02-27 4 FORM 4 SUBMISSION 0001209191-23-013468 8815
2023-02-14 SC 13G/A acad13gadec22.txt 0000080255-23-002572 005-80011 34 7083
2023-02-13 4 FORM 4 SUBMISSION 0001209191-23-008875 8255
2023-02-13 3 FORM 3 SUBMISSION 0001209191-23-008874 5323
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-015189 005-80011 23602191 34 13014
2023-02-09 SC 13G/A filing.txt 0000315066-23-001363 005-80011 23601281 34 8038
2023-02-07 S-8 S-8 0001193125-23-025930 333-269611 23592544 33 273665
2023-02-01 SC 13G/A us0042251084_013123.txt 0001306550-23-005947 005-80011 23573937 34 13481
2023-01-17 4 FORM 4 SUBMISSION 0001209191-23-003554 8548
2023-01-17 SC 13D/A SC 13D/A 0001104659-23-004260 005-80011 23531884 34 128368
2023-01-17 4 FORM 4 SUBMISSION 0001209191-23-003525 28354
2023-01-10 4 FORM 4 SUBMISSION 0001209191-23-002900 9295
2023-01-10 4 FORM 4 SUBMISSION 0001209191-23-002895 12325
2023-01-10 4 FORM 4 SUBMISSION 0001209191-23-002894 9530
2022-11-22 4 FORM 4 SUBMISSION 0001209191-22-058391 9319
2022-11-03 10-Q 10-Q 0000950170-22-021438 000-50768 221355831 34 9434412 1 1
2022-11-02 8-K 8-K 2.02,9.01 0000950170-22-021222 000-50768 221354014 34 521812 1 1
2022-10-28 8-K 8-K 5.02 0001193125-22-272491 000-50768 221342071 34 143454 1 1
2022-10-18 4 FORM 4 SUBMISSION 0001209191-22-054027 8798
2022-10-18 4 FORM 4 SUBMISSION 0001209191-22-054026 8776
2022-10-14 4 FORM 4 SUBMISSION 0001209191-22-053710 7802
2022-10-14 3 FORM 3 SUBMISSION 0001209191-22-053708 5207
2022-10-13 8-K 8-K 5.02 0001193125-22-262140 000-50768 221309134 34 144898 1 1
2022-08-09 S-8 S-8 0001193125-22-215187 333-266680 221145929 33 194564
2022-08-09 10-Q 10-Q 0000950170-22-015642 000-50768 221145759 34 8776414 1 1
2022-08-08 8-K 8-K 2.02,9.01 0000950170-22-015527 000-50768 221144474 34 497355 1 1
2022-06-10 4 FORM 4 SUBMISSION 0001209191-22-036176 9355
2022-06-10 8-K 8-K 5.02,5.07 0001193125-22-171917 000-50768 221008779 34 161674 1 1
2022-06-09 4 FORM 4 SUBMISSION 0001209191-22-035670 7930
2022-06-09 4 FORM 4 SUBMISSION 0001209191-22-035668 7924
2022-06-09 4 FORM 4 SUBMISSION 0001209191-22-035666 7761
2022-06-09 4 FORM 4 SUBMISSION 0001209191-22-035663 7871
2022-06-09 4 FORM 4 SUBMISSION 0001209191-22-035662 7901
2022-06-09 4 FORM 4 SUBMISSION 0001209191-22-035496 25443
2022-05-25 S-3ASR S-3ASR 0001193125-22-159685 333-265205 22962948 33 271361
2022-05-13 DEFR14A DEFR14A 0001564590-22-020163 000-50768 22924024 34 6190358
2022-05-05 10-Q 10-Q 0000950170-22-007468 000-50768 22893112 34 7885170 1 1
2022-05-04 8-K 8-K 2.02,9.01 0000950170-22-007402 000-50768 22891920 34 410646 1 1
2022-05-04 CT ORDER filename1.pdf 20220504,20220504 9999999997-22-002507 000-50768 22890733 34 159211
2022-05-03 4 FORM 4 SUBMISSION 0001209191-22-026941 9298
2022-05-03 4 FORM 4 SUBMISSION 0001209191-22-026940 9315
2022-05-03 4 FORM 4 SUBMISSION 0001209191-22-026938 9304
2022-05-03 4 FORM 4 SUBMISSION 0001209191-22-026937 9336
2022-04-29 DEF 14A DEF 14A 0001564590-22-016850 000-50768 22877337 34 6473987
2022-04-11 4 FORM 4 SUBMISSION 0001209191-22-024064 8825
2022-04-08 8-K 8-K 5.02 0001193125-22-100541 000-50768 22817982 34 144920 1 1
2022-04-07 4 FORM 4 SUBMISSION 0001209191-22-023743 7901
2022-04-07 4 FORM 4 SUBMISSION 0001209191-22-023742 7907
2022-04-07 4 FORM 4 SUBMISSION 0001209191-22-023741 7911
2022-04-07 4 FORM 4 SUBMISSION 0001209191-22-023740 10410
2022-04-07 4 FORM 4 SUBMISSION 0001209191-22-023739 10425
2022-04-07 4 FORM 4 SUBMISSION 0001209191-22-023737 10403
2022-03-01 10-K 10-K 0000950170-22-002392 000-50768 22693683 34 14294676 1 1
2022-02-28 8-K 8-K 2.02,9.01 0000950170-22-002291 000-50768 22689612 34 469225 1 1
2022-02-25 4 FORM 4 SUBMISSION 0001209191-22-013286 8804
2022-02-25 4 FORM 4 SUBMISSION 0001209191-22-013284 8812
2022-02-25 4 FORM 4 SUBMISSION 0001209191-22-013281 8811
2022-02-25 4 FORM 4 SUBMISSION 0001209191-22-013277 8809
2022-02-25 4 FORM 4 SUBMISSION 0001209191-22-013275 8807
2022-02-25 4 FORM 4 SUBMISSION 0001209191-22-013273 8788
2022-02-14 SC 13G acad13gdec21.txt 0000080255-22-002027 005-80011 34 6847
2022-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-22-016358 005-80011 22606240 34 13009
2022-02-09 SC 13G/A filing.txt 0000315066-22-000820 005-80011 22604123 34 8331
2022-02-04 SC 13G us0042251084_020422.txt 0000834237-22-007253 005-80011 22593475 34 13441
2022-01-10 4 FORM 4 SUBMISSION 0001209191-22-002751 9043
2022-01-10 4 FORM 4 SUBMISSION 0001209191-22-002750 9087
2022-01-10 4 FORM 4 SUBMISSION 0001209191-22-002749 8808
2022-01-10 4 FORM 4 SUBMISSION 0001209191-22-002748 9013
2021-12-21 8-K 8-K 8.01,9.01 0001193125-21-362806 000-50768 211506697 34 6378822 1 1
2021-12-20 3 FORM 3 SUBMISSION 0001209191-21-070630 13370
2021-12-14 8-K 8-K 5.02,9.01 0001193125-21-356869 000-50768 211491639 34 159503 1 1
2021-12-06 8-K 8-K 8.01,9.01 0001193125-21-349137 000-50768 211473897 34 186832 1 1
2021-11-23 4 FORM 4 SUBMISSION 0001209191-21-066570 8803
2021-11-19 4 FORM 4 SUBMISSION 0001209191-21-065928 8300
2021-11-19 4 FORM 4 SUBMISSION 0001209191-21-065926 8303
2021-11-09 10-Q 10-Q 0001564590-21-055347 000-50768 211389213 34 7562614 1 1
2021-11-08 8-K 8-K 2.02,9.01 0001564590-21-055255 000-50768 211388145 34 465262 1 1
2021-11-05 3 FORM 3 SUBMISSION 0001209191-21-063186 14268
2021-11-05 8-K 8-K 5.02,9.01 0001193125-21-321667 000-50768 211385058 34 166013 1 1
2021-10-19 4 FORM 4 SUBMISSION 0001209191-21-060958 8801
2021-10-19 4 FORM 4 SUBMISSION 0001209191-21-060957 9004
2021-10-01 4 FORM 4 SUBMISSION 0001209191-21-058556 7034
2021-09-02 8-K 8-K 5.02 0001193125-21-264582 000-50768 211234028 34 144364 1 1
2021-08-05 10-Q 10-Q 0001564590-21-040986 000-50768 211145409 34 7489727 1 1
2021-08-04 8-K 8-K 2.02,9.01 0001564590-21-040825 000-50768 211144206 34 469229 1 1
2021-06-24 8-K 8-K 5.07 0001193125-21-198782 000-50768 211043593 34 155365 1 1
2021-06-24 4 FORM 4 SUBMISSION 0001209191-21-043043 7871
2021-06-24 4 FORM 4 SUBMISSION 0001209191-21-043041 7762
2021-06-24 4 FORM 4 SUBMISSION 0001209191-21-043039 7930
2021-06-24 4 FORM 4 SUBMISSION 0001209191-21-043037 7924
2021-06-24 4 FORM 4 SUBMISSION 0001209191-21-043035 7901
2021-06-24 4 PRIMARY DOCUMENT 0001638599-21-000591 25298
2021-05-12 DEFR14A DEFR14A 0001564590-21-027021 000-50768 21915432 34 4860010
2021-05-06 10-Q 10-Q 0001564590-21-024268 000-50768 21894958 34 7834048 1 1
2021-05-05 8-K 8-K 2.02,9.01 0001564590-21-024085 000-50768 21893598 34 392920 1 1
2021-04-30 4 FORM 4 SUBMISSION 0001209191-21-029359 8785
2021-04-30 4 FORM 4 SUBMISSION 0001209191-21-029358 9183
2021-04-30 4 FORM 4 SUBMISSION 0001209191-21-029357 8796
2021-04-30 4 FORM 4 SUBMISSION 0001209191-21-029356 9181
2021-04-30 DEF 14A DEF 14A 0001564590-21-022589 000-50768 21879231 34 2978986
2021-04-05 8-K 8-K 7.01,8.01,9.01 0001193125-21-105632 000-50768 21803771 34 3452239 1 1
2021-04-02 SEC STAFF LETTER filename1.pdf 9999999997-21-001103 274644
2021-03-08 8-K 8-K 8.01,9.01 0001193125-21-073270 000-50768 21722337 34 169578 1 1
2021-03-05 SEC STAFF LETTER filename1.pdf 9999999997-21-000960 276375
2021-02-25 4 FORM 4 SUBMISSION 0001209191-21-014561 7905
2021-02-25 4 FORM 4 SUBMISSION 0001209191-21-014560 7905
2021-02-25 4 FORM 4 SUBMISSION 0001209191-21-014559 7892
2021-02-25 4 FORM 4 SUBMISSION 0001209191-21-014558 7888
2021-02-25 4 FORM 4 SUBMISSION 0001209191-21-014557 7886
2021-02-25 10-K 10-K 0001564590-21-008372 000-50768 21676204 34 13998063 1 1
2021-02-24 8-K 8-K 2.02,9.01 0001564590-21-008087 000-50768 21673192 34 476631 1 1
2021-02-16 SC 13G/A acad13gadec20.txt 0000080255-21-001129 005-80011 34 7053
2021-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-21-017327 005-80011 21609939 34 13880
2021-02-08 4 FORM 4 SUBMISSION 0001209191-21-008661 6761
2021-02-08 4 FORM 4 SUBMISSION 0001209191-21-008659 14613
2021-02-08 4 FORM 4 SUBMISSION 0001209191-21-008660 14639
2021-02-08 4 FORM 4 SUBMISSION 0001209191-21-008658 6757
2021-02-08 SC 13G/A filing.txt 0000315066-21-000808 005-80011 21599347 34 8484
2021-01-27 8-K 8-K 5.02 0001193125-21-019333 000-50768 21561048 34 144008 1 1
2021-01-14 4 FORM 4 SUBMISSION 0001209191-21-003678 9308
2021-01-08 4 FORM 4 SUBMISSION 0001209191-21-002836 8944
2021-01-08 4 FORM 4 SUBMISSION 0001209191-21-002834 9183
2021-01-08 4 FORM 4 SUBMISSION 0001209191-21-002832 8940
2021-01-08 4 FORM 4 SUBMISSION 0001209191-21-002831 28268
2021-01-08 4 FORM 4 SUBMISSION 0001209191-21-002830 9163
2020-11-20 4 FORM 4 SUBMISSION 0001209191-20-059854 8804
2020-11-04 10-Q 10-Q 0001564590-20-050566 000-50768 201287475 34 7405374 1 1
2020-11-04 8-K 8-K 2.02,9.01 0001564590-20-050530 000-50768 201287223 34 482504 1 1
2020-10-29 4 FORM 4 SUBMISSION 0001209191-20-056219 9497
2020-10-19 4 FORM 4 SUBMISSION 0001209191-20-055317 8793
2020-10-19 4 FORM 4 SUBMISSION 0001209191-20-055316 8801
2020-10-19 4 FORM 4 SUBMISSION 0001209191-20-055315 8780
2020-10-01 8-K FORM 8-K 5.02 0001193125-20-261480 000-50768 201217244 34 178990 1 1
2020-10-01 4 FORM 4 SUBMISSION 0001209191-20-052665 7827
2020-10-01 3 FORM 3 SUBMISSION 0001209191-20-052659 5035
2020-08-25 S-3ASR S-3ASR 0001193125-20-229312 333-248401 201129692 33 200525
2020-08-25 8-K 8-K 3.02,8.01,9.01 0001193125-20-229278 000-50768 201129656 34 166225 1 1
2020-08-07 3/A FORM 3/A SUBMISSION 0001209191-20-045697 3305
2020-08-06 8-K 8-K 5.02 0001193125-20-212084 000-50768 201082848 34 145568 1 1

Latest XBRL company facts

One latest value per concept from companyfacts (390 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 172.83M 2026-10-28 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
dei EntityPublicFloat Entity Public Float USD 2.30B 2025-06-30 2025 FY 10-K 2026-02-26 0001193125-26-072519
ecd CoSelectedMeasureAmt CoSelectedMeasureAmt USD 1.07B 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001193125-26-174163
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 4.97M 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001193125-26-174163
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 2.45M 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001193125-26-174163
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 119.92 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001193125-26-174163
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 49.96 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001193125-26-174163
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 16.33M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 161.02M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 642,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 8.46M 2024-06-30 2024 Q2 10-Q 2024-08-07 0000950170-24-092163
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 315.89M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 31.43M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap AccruedRoyaltiesCurrent Accrued Royalties, Current USD 2.45M 2020-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008372
us-gaap AccruedRoyaltiesCurrentAndNoncurrent Accrued Royalties USD 16.35M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 9.48M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -2.94M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 1.48B 2017-03-31 2017 Q1 10-Q 2017-05-09 0001564590-17-009889
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 3.12B 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 52.56M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 292,000 2015-01-01 2015-12-31 2017 FY 10-K 2018-02-27 0001564590-18-003526
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 509,000 2009-01-01 2009-12-31 2011 FY 10-K 2012-03-06 0001193125-12-098990
us-gaap AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net USD 596,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-27 0001564590-19-004596
us-gaap AdvertisingExpense Advertising Expense USD 31.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 49.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap AllowanceForDoubtfulAccountsReceivableWriteOffs Accounts Receivable, Allowance for Credit Loss, Writeoff USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-27 0001564590-20-006889
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 8.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 12.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap Assets Assets USD 1.79B 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap AssetsCurrent Assets, Current USD 1.27B 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 4,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 3.93M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 658.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 26.60M 2013-03-31 2013 Q1 10-Q 2013-05-07 0001193125-13-204467
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax USD 13,000 2015-06-30 2015 Q2 10-Q 2015-08-06 0001193125-15-281018
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax USD 11,000 2015-06-30 2015 Q2 10-Q 2015-08-06 0001193125-15-281018
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss USD 1,000 2020-06-30 2020 Q2 10-Q 2020-08-06 0001564590-20-036993
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss USD 40,000 2021-09-30 2021 Q3 10-Q 2021-11-09 0001564590-21-055347
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value USD 257.34M 2021-09-30 2021 Q3 10-Q 2021-11-09 0001564590-21-055347
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss USD 40,000 2021-09-30 2021 Q3 10-Q 2021-11-09 0001564590-21-055347
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value USD 257.34M 2021-09-30 2021 Q3 10-Q 2021-11-09 0001564590-21-055347
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value USD 4.00M 2020-06-30 2020 Q2 10-Q 2020-08-06 0001564590-20-036993
us-gaap AvailableForSaleSecuritiesCurrent Available-for-sale Securities, Current USD 83.03M 2013-03-31 2013 Q1 10-Q 2013-05-07 0001193125-13-204467
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 260.63M 2014-12-31 2014 FY 10-K 2015-02-26 0001193125-15-066078
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 654.08M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap AvailableForSaleSecuritiesFairValueDisclosure Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) USD 87.78M 2013-03-31 2013 Q1 10-Q 2013-05-07 0001193125-13-204467
us-gaap AvailableforsaleSecuritiesGrossUnrealizedGain Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) USD 27,000 2013-03-31 2013 Q1 10-Q 2013-05-07 0001193125-13-204467
us-gaap AvailableForSaleSecuritiesGrossUnrealizedLosses1 Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) USD 16,000 2013-03-31 2013 Q1 10-Q 2013-05-07 0001193125-13-204467
us-gaap BankingRegulationMaximumPayoutAmount BankingRegulationMaximumPayoutAmount USD 11.80M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-28 0000950170-23-004757
us-gaap CapitalLeaseObligationsCurrent Capital Lease Obligations, Current USD 32,000 2011-12-31 2012 FY 10-K 2013-03-12 0001193125-13-103111
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 322.37M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -94.20M 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-27 0001564590-18-003526
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 119.15M 2018-03-31 2018 Q1 10-Q 2018-05-04 0001564590-18-010844
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 330.21M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 144.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) USD/Right 0.01 2012-12-31 2014 FY 10-K 2015-02-26 0001193125-15-066078
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0.01 2012-12-31 2019 FY 10-K 2020-02-27 0001564590-20-006889
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 0.35 2011-01-31 2015 FY 10-K 2016-02-29 0001193125-16-483533
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 493,145 2019-12-31 2019 FY 10-K 2020-02-27 0001564590-20-006889
us-gaap ClassOfWarrantOrRightUnissued Class of Warrant or Right, Unissued shares 1.97M 2014-12-31 2014 FY 10-K 2015-02-26 0001193125-15-066078
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 225.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 172.79M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 172.79M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap CommonStockValue Common Stock, Value, Issued USD 17,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD 84.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap ContractualObligation Contractual Obligation USD 35.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap ContractualObligationDueInNextTwelveMonths Contractual Obligation, to be Paid, Year One USD 50.00M 2024-06-30 2024 Q2 10-Q 2024-08-07 0000950170-24-092163
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 88.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap CostOfGoodsSold Cost of Goods Sold (Deprecated 2018-01-31) USD 2.15M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-04 0001564590-18-010844
us-gaap CostsAndExpenses Costs and Expenses USD 813.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease Cumulative Translation Adjustment, Net of Tax, Period Increase (Decrease) USD 539,000 2011-04-01 2011-04-30 2013 FY 10-K 2014-02-27 0001193125-14-073040
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD -4.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 213,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD -1.77M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 2.82M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 23.45M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss USD 56,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 611.13M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss USD 3.87M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap DebtSecuritiesAvailableForSaleMaturityAfterOneThroughFiveYearsWeightedAverageYield Debt Securities, Available-for-Sale, Weighted Average Yield, Maturity, after Year One Through Five pure 0.4 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap DebtSecuritiesAvailableForSaleMaturityWithinOneYearWeightedAverageYield Debt Securities, Available-for-Sale, Weighted Average Yield, Maturity, Year One pure 0.6 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap DebtSecuritiesAvailableForSaleRealizedLoss Debt Securities, Available-for-sale, Realized Loss USD 500,000 2023-01-01 2023-03-31 2024 FY 10-K 2025-02-27 0000950170-25-029253
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 634.57M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss USD 3.93M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions Security 75 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap DebtSecuritiesAvailableForSaleWeightedAverageYield DebtSecuritiesAvailableForSaleWeightedAverageYield pure 1 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap DeferredCompensationArrangementWithIndividualCashAwardGrantedAmount Deferred Compensation Arrangement with Individual, Cash Award Granted, Amount USD 15.10M 2021-11-02 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap DeferredCompensationArrangementWithIndividualEmployerContribution Deferred Compensation Arrangement with Individual, Employer Contribution (Deprecated 2017-01-31) USD 240,000 2013-01-01 2013-12-31 2013 FY 10-K 2014-02-27 0001193125-14-073040
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD -212.45M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD -11.21M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 226.72M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap DeferredIncomeTaxesAndTaxCredits Deferred Income Taxes and Tax Credits USD 24.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -250.32M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 11.16M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 2.64M 2016-12-31 2017 FY 10-K 2018-02-27 0001564590-18-003526
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 2.59M 2011-12-31 2012 FY 10-K 2013-03-12 0001193125-13-103111
us-gaap DeferredRevenueRevenueRecognized1 Deferred Revenue, Revenue Recognized USD 0 2017-07-01 2017-09-30 2017 Q3 10-Q 2017-11-07 0001564590-17-022271
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD -26.66M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap DeferredTaxAssetsCharitableContributionCarryforwards Deferred Tax Assets, Charitable Contribution Carryforwards USD 33.77M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 1.20M 2011-12-31 2012 FY 10-K 2013-03-12 0001193125-13-103111
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 47.32M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 375.64M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 92.96M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 249.88M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 39.40M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 77.12M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 21.68M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 51,000 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-021473
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 52.48M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 37.99M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 114.60M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 0 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-021473
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 7.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay pure 0.05 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 0.6 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap Depreciation Depreciation USD 1.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 206,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-26 0001193125-15-066078
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 0.52 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.7 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-05 0000950170-22-007468
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 0.51 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.322 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -1.78 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap EffectiveIncomeTaxRateReconciliationDeductions Effective Income Tax Rate Reconciliation, Deduction, Percent pure 0.316 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-07 0001193125-26-209731
us-gaap EffectiveIncomeTaxRateReconciliationGiltiAmount EffectiveIncomeTaxRateReconciliationGiltiAmount USD 1.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap EffectiveIncomeTaxRateReconciliationGiltiPercent EffectiveIncomeTaxRateReconciliationGiltiPercent pure 0.014 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0.014 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent pure 0.014 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure 0.124 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.179 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.076 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD -6,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-27 0001564590-18-003526
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -2,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-04 0001564590-18-010844
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 211,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 44.38M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount Share-based Payment Arrangement, Amount Capitalized USD 57,000 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-02 0001564590-19-014909
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 62.10M 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-021473
us-gaap EquityIssuancePerShareAmount Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) USD 4.43 2012-12-01 2012-12-31 2014 FY 10-K 2015-02-26 0001193125-15-066078
us-gaap EquityMethodInvestments Equity Method Investments USD 2.90M 2018-06-30 2018 Q2 10-Q 2018-08-08 0001564590-18-020524
us-gaap EquitySecuritiesFvNi Equity Securities, FV-NI USD 373.27M 2021-12-31 2021 FY 10-K 2022-03-01 0000950170-22-002392
us-gaap EquitySecuritiesFvNiCost Equity Securities, FV-NI, Cost USD 373.48M 2021-12-31 2021 FY 10-K 2022-03-01 0000950170-22-002392
us-gaap ExcessTaxBenefitFromShareBasedCompensationFinancingActivities Excess Tax Benefit from Share-based Compensation, Financing Activities USD 596,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-27 0001564590-19-004596
us-gaap ExcessTaxBenefitFromShareBasedCompensationOperatingActivities Excess Tax Benefit from Share-based Compensation, Operating Activities USD 596,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-27 0001564590-19-004596
us-gaap FairValueAssumptionsExpectedDividendRate Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) pure 0 2011-01-01 2011-01-31 2015 FY 10-K 2016-02-29 0001193125-16-483533
us-gaap FairValueAssumptionsExpectedVolatilityRate Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) pure 1.058 2012-12-01 2012-12-31 2015 FY 10-K 2016-02-29 0001193125-16-483533
us-gaap FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) pure 0.011 2012-12-01 2012-12-31 2015 FY 10-K 2016-02-29 0001193125-16-483533
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) USD -4.11M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029253
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 0 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029253
us-gaap FinancialLiabilitiesFairValueDisclosure Financial Liabilities Fair Value Disclosure USD 4.51M 2023-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029253
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 1.10M 2016-09-30 2016 Q3 10-Q 2016-11-07 0001564590-16-027956
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months USD 400,000 2021-06-30 2021 Q2 10-Q 2021-08-05 0001564590-21-040986
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 1.50M 2016-12-31 2016 FY 10-K 2017-02-28 0001564590-17-002866
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 400,000 2020-09-30 2020 Q3 10-Q 2020-11-04 0001564590-20-050566
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 1.00M 2017-12-31 2017 FY 10-K 2018-02-27 0001564590-18-003526
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 1.00M 2019-12-31 2019 FY 10-K 2020-02-27 0001564590-20-006889
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 1.50M 2019-12-31 2019 FY 10-K 2020-02-27 0001564590-20-006889
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 1.10M 2020-06-30 2020 Q2 10-Q 2020-08-06 0001564590-20-036993
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 135.48M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap ForeignIncomeTaxExpenseBenefitContinuingOperations Foreign Income Tax Expense (Benefit), Continuing Operations USD 200,000 2020-01-01 2020-12-31 2022 FY 10-K 2023-02-28 0000950170-23-004757
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-28 0000950170-23-004757
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -166,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap GainLossOnDispositionOfIntangibleAssets Gain (Loss) on Disposition of Intangible Assets USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap GainLossOnSaleOfOtherAssets Gain (Loss) on Disposition of Other Assets USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 10,000 2013-01-01 2013-12-31 2013 FY 10-K 2014-02-27 0001193125-14-073040
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 27.49M 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-05 0001564590-16-017989
us-gaap GrossProfit Gross Profit USD 684.80M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-021473
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD 72.16M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD 130.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 66.75M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -280.97M 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008372
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD 138.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap IncomeTaxesPaid Income Taxes Paid USD 24.04M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 25.17M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 0 2022-12-31 2022 FY 10-K 2023-02-28 0000950170-23-004757
us-gaap IncomeTaxExaminationPenaltiesExpense Income Tax Examination, Penalties Expense USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0000950170-22-002392
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 42.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability USD 2.78M 2013-01-01 2013-12-31 2015 FY 10-K 2016-02-29 0001193125-16-483533
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -247.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap IncomeTaxReconciliationDeductions Effective Income Tax Rate Reconciliation, Deduction, Amount USD -2.78M 2013-01-01 2013-12-31 2014 FY 10-K 2015-02-26 0001193125-15-066078
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD -13.71M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD 29.31M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 1.92M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount USD 1.89M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 17.18M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 154,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -24.82M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 5.96M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 10.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 5.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 39.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets Increase (Decrease) in Accounts Receivable and Other Operating Assets USD -9.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 9.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -2.64M 2017-01-01 2017-12-31 2019 FY 10-K 2020-02-27 0001564590-20-006889
us-gaap IncreaseDecreaseInDeferredCompensation Increase (Decrease) in Deferred Compensation USD 10.70M 2024-09-01 2024-09-30 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -2.64M 2017-01-01 2017-09-30 2018 Q3 10-Q 2018-11-06 0001564590-18-027431
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD -5.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap IncreaseDecreaseInOperatingAssets Increase (Decrease) in Operating Assets USD -1.13M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-01 0001564590-19-027565
us-gaap IncreaseDecreaseInOperatingLiabilities Increase (Decrease) in Operating Liabilities USD -1.08M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-01 0001564590-19-027565
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -574,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD -2.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 3.85M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 5.07M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-07 0001193125-26-209731
us-gaap IncreaseDecreaseInPrepaidExpensesOther Increase (Decrease) in Prepaid Expenses, Other USD 13.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD 2.00M 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-04 0001564590-16-022733
us-gaap IncreaseDecreaseInRestrictedCashForOperatingActivities Increase (Decrease) in Restricted Cash for Operating Activities USD 100,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-27 0001564590-18-003526
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 0 2021-12-31 2021 FY 10-K 2022-03-01 0000950170-22-002392
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD 24.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 8,000 2011-01-01 2011-12-31 2011 FY 10-K 2012-03-06 0001193125-12-098990
us-gaap InterestReceivableCurrent Interest Receivable, Current USD 17.30M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 1.16M 2017-12-31 2017 FY 10-K 2018-02-27 0001564590-18-003526
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 34.10M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap InventoryForLongTermContractsOrPrograms Inventory for Long-term Contracts or Programs, Gross USD 66.48M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap InventoryNet Inventory, Net USD 106.84M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 4.08M 2017-12-31 2017 FY 10-K 2018-02-27 0001564590-18-003526
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 60.77M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 11.97M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap InventoryWriteDown Inventory Write-down USD 2.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap InvestmentIncomeNet Investment Income, Net USD 41,000 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-07 0001193125-13-204467
us-gaap InvestmentIncomeNetAmortizationOfDiscountAndPremium Investment Income, Net, Amortization of Discount and Premium USD -105,000 2011-01-01 2011-12-31 2011 FY 10-K 2012-03-06 0001193125-12-098990
us-gaap InvestmentIncomeNonoperating Investment Income, Nonoperating USD 13,000 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-08 0001193125-12-218369
us-gaap InvestmentOwnedAtFairValue Investment Owned, at Fair Value USD 275.60M 2014-03-31 2014 Q1 10-Q 2014-05-06 0001193125-14-184864
us-gaap InvestmentsFairValueDisclosure Investments, Fair Value Disclosure USD 735.64M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap JointlyOwnedUtilityPlantProportionateOwnershipShare Jointly Owned Utility Plant, Proportionate Ownership Share pure 0.5 2022-01-31 2021 FY 10-K 2022-03-01 0000950170-22-002392
us-gaap LeaseCost Lease, Cost USD 12.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 90.33M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 3.66M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 15.25M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 8.90M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 12.82M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 15.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 15.45M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 3.75M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 18.48M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap Liabilities Liabilities USD 406.66M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 1.79B 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap LiabilitiesAssumed1 Liabilities Assumed USD 4.50M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-021473
us-gaap LiabilitiesCurrent Liabilities, Current USD 332.22M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 1.56M 2018-12-31 2018 FY 10-K 2019-02-27 0001564590-19-004596
us-gaap LicenseCosts License Costs (Deprecated 2018-01-31) USD 1.33M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-04 0001564590-18-010844
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 22,000 2012-03-31 2012 Q1 10-Q 2012-05-08 0001193125-12-218369
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 26.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 2.88M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-04 0001564590-18-010844
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -28.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD 89.62M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-04 0001564590-18-010844
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD 146.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -45.24M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-04 0001564590-18-010844
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 88.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD 88.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD 88.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap NetSharesReclassifiedToMandatorilyRedeemableCapitalStockValue Net Shares Reclassified to Mandatorily Redeemable Capital Stock, Value USD 17.66M 2012-01-01 2012-12-31 2014 FY 10-K 2015-02-26 0001193125-15-066078
us-gaap NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification (Deprecated 2020-01-31) USD -289,000 2017-01-01 2017-12-31 2019 FY 10-K 2020-02-27 0001564590-20-006889
us-gaap NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 Noncash or Part Noncash Acquisition, Fixed Assets Acquired USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap OperatingExpenses Operating Expenses USD 50.27M 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-05 0001564590-16-017989
us-gaap OperatingIncomeLoss Operating Income (Loss) USD 104.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap OperatingLeaseCost Operating Lease, Cost USD 14.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 71.85M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 14.53M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 57.32M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap OperatingLeasePayments Operating Lease, Payments USD 9.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 67.47M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 68.28M 2018-12-31 2019 FY 10-K 2020-02-27 0001564590-20-006889
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 4.77M 2018-12-31 2019 FY 10-K 2020-02-27 0001564590-20-006889
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 6.57M 2018-12-31 2019 FY 10-K 2020-02-27 0001564590-20-006889
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 7.18M 2018-12-31 2019 FY 10-K 2020-02-27 0001564590-20-006889
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 6.91M 2018-12-31 2019 FY 10-K 2020-02-27 0001564590-20-006889
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 4.17M 2018-12-31 2019 FY 10-K 2020-02-27 0001564590-20-006889
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 38.68M 2018-12-31 2019 FY 10-K 2020-02-27 0001564590-20-006889
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 748,000 2018-09-30 2018 Q3 10-Q 2018-11-06 0001564590-18-027431
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 4.50M 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-27 0001564590-19-004596
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.062 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 100,000 2021-12-31 2021 FY 10-K 2022-03-01 0000950170-22-002392
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 18.24M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 3.32M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax (Deprecated 2012-01-31) USD -512,000 2011-01-01 2011-12-31 2011 FY 10-K 2012-03-06 0001193125-12-098990
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD 107,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD 1.15M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -4.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap OtherExpenses Other Expenses USD 1.50M 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-08 0001564590-20-023050
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 17.12M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap OtherNoncashExpense Other Noncash Expense USD 806,000 2011-01-01 2011-12-31 2013 FY 10-K 2014-02-27 0001193125-14-073040
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 7,000 2013-01-01 2013-03-31 2014 Q1 10-Q 2014-05-06 0001193125-14-184864
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 241,000 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-01 0001564590-19-027565
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 1.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap OtherOperatingActivitiesCashFlowStatement Other Operating Activities, Cash Flow Statement USD 5,000 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-07 0001193125-13-204467
us-gaap OtherSalesRevenueNet Other Revenue, Net (Deprecated 2018-01-31) USD 4,000 2016-01-01 2016-12-31 2017 FY 10-K 2018-02-27 0001564590-18-003526
us-gaap OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities Other than Temporary Impairment Losses, Investments, Available-for-sale Securities USD 0 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-10 0001193125-14-406106
us-gaap PaymentsForProceedsFromProductiveAssets Payments for (Proceeds from) Productive Assets USD 63,000 2013-01-01 2013-06-30 2013 Q2 10-Q 2013-08-06 0001193125-13-321550
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 292,000 2015-01-01 2015-12-31 2017 FY 10-K 2018-02-27 0001564590-18-003526
us-gaap PaymentsToAcquireAvailableForSaleSecurities Payments to Acquire Available-for-sale Securities USD 453.85M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-09 0001564590-21-055347
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 276.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesEquity Payments to Acquire Available-for-sale Securities, Equity USD 3.15M 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008372
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 11.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap PrepaidAdvertising Prepaid Advertising USD 900,000 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 73.31M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 64.60M 2026-03-31 2026 Q1 10-Q 2026-05-07 0001193125-26-209731
us-gaap ProceedsFromContributedCapital Proceeds from Contributed Capital USD 14.32M 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-27 0001564590-19-004596
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 26.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 54.05M 2011-01-01 2011-12-31 2011 FY 10-K 2012-03-06 0001193125-12-098990
us-gaap ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale USD 259.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap ProceedsFromSaleOfAvailableForSaleSecuritiesDebt Proceeds from Sale of Debt Securities, Available-for-sale USD 183.00M 2023-01-01 2023-03-31 2024 FY 10-K 2025-02-27 0000950170-25-029253
us-gaap ProceedsFromSaleOfMachineryAndEquipment Proceeds from Sale of Machinery and Equipment USD 9,000 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-08 0001193125-12-218369
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 44,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-02-27 0001564590-20-006889
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 20.30M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-021473
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD 88.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap PropertyPlantAndEquipmentDisposals Property, Plant and Equipment, Disposals USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 17.00M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 18.40M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 9,000 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-08 0001193125-12-218369
us-gaap RepaymentsOfLongTermDebtAndCapitalSecurities Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security USD 32,000 2012-01-01 2012-12-31 2014 FY 10-K 2015-02-26 0001193125-15-066078
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 234.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-28 0000950170-23-004757
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 2.83M 2018-03-31 2018 Q1 10-Q 2018-05-04 0001564590-18-010844
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 7.85M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -1.72B 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 918.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap Revenues Revenues USD 726.44M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-021473
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 9.45M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 1 2011-01-01 2011-01-31 2015 FY 10-K 2016-02-29 0001193125-16-483533
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 31.31 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-021473
us-gaap SalesRevenueGoodsNet Sales Revenue, Goods, Net (Deprecated 2018-01-31) USD 48.87M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-04 0001564590-18-010844
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 490.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 49.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 Share-based Payment Arrangement, Expensed and Capitalized, Amount USD 3.60M 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value USD 5.20M 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 230.16M 2020-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008372
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 9.69M 2020-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008372
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 29.71 2020-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008372
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 7.90M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-021473
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 1.83M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-021473
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 4.24M 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-29 0001193125-16-483533
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 3.16M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-021473
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 13.25 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-021473
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 5.47M 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-021473
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 90.96M 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-021473
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 16.63M 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-021473
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 28.75 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-021473
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 4.59M 2018-12-31 2018 FY 10-K 2019-02-27 0001564590-19-004596
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 19.87M 2018-12-31 2018 FY 10-K 2019-02-27 0001564590-19-004596
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 28.04 2018-12-31 2018 FY 10-K 2019-02-27 0001564590-19-004596
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 11.15M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-021473
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent pure 0.15 2013-01-01 2013-12-31 2013 FY 10-K 2014-02-27 0001193125-14-073040
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 19.42 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-021473
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 32.07 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-021473
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 21.99 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-021473
us-gaap StateAndLocalIncomeTaxExpenseBenefitContinuingOperations State and Local Income Tax Expense (Benefit), Continuing Operations USD 31.60M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029253
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 1.39B 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans Stock Issued During Period, Shares, Employee Stock Purchase Plans shares 68,793 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-29 0001193125-16-483533
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 7.19M 2019-09-01 2019-09-30 2021 FY 10-K 2022-03-01 0000950170-22-002392
us-gaap StockIssuedDuringPeriodSharesOther Stock Issued During Period, Shares, Other shares 782,339 2011-04-01 2011-04-30 2013 FY 10-K 2014-02-27 0001193125-14-073040
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 1.05M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-021473
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-28 0000950170-23-004757
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 5.51M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 44.28M 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008372
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 44.28M 2020-01-01 2020-12-31 2022 FY 10-K 2023-02-28 0000950170-23-004757
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 1.32M 2011-01-01 2011-12-31 2013 FY 10-K 2014-02-27 0001193125-14-073040
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 44.37M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap SubleaseIncome Sublease Income USD 1.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap TaxCutsAndJobsActOf2017IncompleteAccountingExistingIncomeTaxExpenseBenefit Tax Cuts and Jobs Act, Incomplete Accounting, Existing Income Tax Expense (Benefit) (Deprecated 2020-01-31) USD -1.09M 2017-01-01 2017-12-31 2019 FY 10-K 2020-02-27 0001564590-20-006889
us-gaap TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit Tax Cuts and Jobs Act, Incomplete Accounting, Provisional Income Tax Expense (Benefit) (Deprecated 2020-01-31) USD 1.10M 2017-01-01 2017-12-31 2019 FY 10-K 2020-02-27 0001564590-20-006889
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0 2013-12-31 2013 FY 10-K 2014-02-27 0001193125-14-073040
us-gaap TemporaryEquityRedemptionValue Temporary Equity, Redemption Value (Deprecated 2014-01-31) USD 17.66M 2012-12-31 2013 FY 10-K 2014-02-27 0001193125-14-073040
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2013-12-31 2013 FY 10-K 2014-02-27 0001193125-14-073040
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2013-12-31 2013 FY 10-K 2014-02-27 0001193125-14-073040
us-gaap TemporaryEquityStockIssuedDuringPeriodValueNewIssues Temporary Equity, Stock Issued During Period, Value, New Issues USD 17.09M 2012-01-01 2012-12-31 2014 FY 10-K 2015-02-26 0001193125-15-066078
us-gaap UnrealizedGainLossOnSecurities Unrealized Gain (Loss) on Securities USD 45,000 2013-01-01 2013-12-31 2013 FY 10-K 2014-02-27 0001193125-14-073040
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 41.58M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 2.05M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 3.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 2.15M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-29 0001193125-16-483533
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 0 2016-12-31 2016 FY 10-K 2017-02-28 0001564590-17-002866
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 340.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-072519
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 127,000 2010-01-01 2010-12-31 2012 FY 10-K 2013-03-12 0001193125-13-103111
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 173.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 161.23M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-05 0000950170-22-007468
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 171.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-447794

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →